DIRS.INFO The most relevant business & tech news

☆ The founder of Lululemon is spending $100 million to try to beat the super rare disease that's destroying his muscles
▼ + stars: | 2023-10-22 | by ( Lakshmi Varanasi | ) www.businessinsider.com time to read: +3 min

Lululemon founder Chip Wilson is battling FSHD, a rare form of muscular dystrophy. He's investing $100 million into finding a cure through his venture philanthropy fund, Solve FSHD. AdvertisementAdvertisementLululemon founder Chip Wilson has been battling a rare muscular disease for the past several decades, and he's funneling $100 million of his multibillion net worth into finding a cure. Wilson suffers from an even more uncommon form called FSHD2 that impacts just 5% of those with the disease, Bloomberg noted. Solve FSHD did not immediately respond to Insider's request for a comment.

Persons: Chip Wilson, FSHD, He's, Wilson Organizations: Morning, Bloomberg, FSHD Society, China's, Anta, Products, Amer Sports

☆ This little-known biotech stock can surge 60% on promising drug trials, Goldman Sachs says
▼ + stars: | 2022-11-15 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

It may be time for investors to jump into little-known biotech stock Fulcrum Therapeutics , according to Goldman Sachs. "We believe p38α/β MAPK inhibitor losmapimod has the potential to be a novel first-in-class therapy in FSHD," Kumar said in a note to clients. He has assumed a 40% probability of success and 40% peak market share for the FSHD drug. About 5% of the world's population carries the trait for hemoglobin disorders like sickle cell disease, according to the World Health Organization . Kumar said its FTX-6058 experimental drug for sickle cell disease, which is called SCD in short, has been promising in early testing.

Search resuls for: "FSHD"

2 mentions found